Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to be predictive of efficacy ...
Researchers at the Max Planck Institute for Molecular Genetics have developed a novel synthetic micropeptide termed the "killswitch" to selectively immobilize proteins within cellular condensates, unveiling crucial connections ...
A collaborative team from the School of Engineering and Applied Science and the Perelman School of Medicine have unraveled the mathematics of a 500-million-year-old protein network that acts like the body's bouncer, "deciding" ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design proteins needed for new treatments.
Two key protein structures in the body are being visualized for the first time, thanks in part to the latest technology in the University of Cincinnati's Center for Advanced Structural Biology—potentially opening the door ...
Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a few seconds. Beyond convenience, state-of-the-art algorithms are finding their way into modern-day ...
To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from Peking University led by Professors Chen Peng and Wang Chu recently developed CAGE-Proxvivo, a computer-aided ...
Malaria remains a persistent public health burden, with Plasmodium falciparum causing the most dangerous form of malaria and the most lethal infections. Its capacity to develop resistance to current treatments underlines ...
Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States alone, the U.S. Centers for Disease Control and Prevention reports that more than one in seven adults ...
Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing attention to peptide-based drugs such as Wegovy, demand for effective peptide therapeutics derived ...
